Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
about
Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic miceMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysisEffect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in miceIncreased response to cholesterol feeding in apolipoprotein C1-deficient miceLipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP miceApoE plasma levels and risk of cardiovascular mortality in old ageGenome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient miceLoss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic miceAbscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wallVascular ligand-receptor mapping by direct combinatorial selection in cancer patients.Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin.Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden miceLow dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.Lipid metabolism in long-lived families: the Leiden Longevity StudyGenome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited.A practical approach to using mice in atherosclerosis research.Animal models of atherosclerosis.Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice.The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic miceModulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Classification for Longevity Potential: The Use of Novel BiomarkersEthanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.Pharmacotherapy of coronary atherosclerosis.Macrophagic CD146 promotes foam cell formation and retention during atherosclerosisMouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation.Most appropriate animal models to study the efficacy of statins: a systematic review.Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation.Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion.Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.Evaluation of antiatherosclerotic drugs by Raman spectroscopy.Atherosclerosis and the mouse: a decade of experience.
P2860
Q27344569-503F1C4E-20AF-403F-8FBB-6D9F8F3F813AQ28070313-E6533C32-53EB-424D-A134-8E261AEF494BQ28222098-04244718-3419-4D5E-95EA-D525910A55ACQ28513259-4DEBEB45-A306-4FE6-B4BE-44419CE15F47Q28587768-C2FD24B2-C75D-4DED-9515-251223FC39DCQ28732458-5264E60B-D515-457A-9592-A89ACADC429EQ33242076-C405C677-8976-411F-9D44-8BF74AE212E3Q33493427-6F5806A8-2A2A-45BA-BF23-1035CEBB0510Q33775709-273D6549-E9E6-4723-B7E7-69C917517BD4Q33905765-A4AD509F-267F-47F6-91B7-EC16AF552571Q33937727-F351E6D5-60A0-4A82-BDB8-C413836E4ECEQ34065835-20D8F4F1-C8E4-4E94-9CDB-A7E7546BC093Q34238694-51014F8B-D34D-41F1-BAF6-34A745CB5C8CQ34466387-AB2E1C06-FC65-49FF-AB2E-079043D1EBE7Q34469947-4142D02B-C3E3-4806-B309-AF755758648AQ34672078-3B019E93-68EF-4429-856D-05BC26671072Q35058473-95C0EA50-6348-4DAD-A2D5-541B69F4F152Q35080214-2278104B-BFC0-4FD7-B4FB-59CBD127EDD8Q35347421-B15E6BAA-9DD4-4362-AFBE-0E0C17048B86Q35754358-2ECA76DE-C7CA-4E92-9197-DFCB3765B5A8Q35903298-040A769D-F442-498B-B6F8-9353E28DC324Q36130584-897D5693-0E28-4C69-AC1D-A2B1552004CCQ37113551-30CA81DA-8B0D-47E4-8664-62AC2D776641Q37230691-F8699C92-6368-4424-A9AD-A780330ABD59Q37352384-32D40818-5642-45B1-B4DF-2C336F1F4504Q37361432-00640CB8-C628-4E90-93C5-F81F8C613F9AQ37373417-80F58F13-8E52-4548-86F8-598C5C79C3C0Q37417026-F042A28F-0298-440E-8241-FF9E510F8AB4Q37519710-32F09A20-8286-460A-8A40-A5244210D8E7Q37683992-A406C675-0AAA-494A-8094-73A279E9E2BAQ38077675-28D3272D-66F2-4A73-8E02-8CAFDEB0C155Q38234426-6B66CE1C-1097-48DA-8DB7-BEED4AD12065Q38781034-1C9109AB-05F9-42E0-992F-E3C65F48873FQ39224276-1A147F7C-F3D3-416B-BCC6-D6CE25906AA4Q39645825-5A006DB3-0937-4656-A277-4C24D846A6B9Q39741648-D7B9CDB8-77D4-48F7-88C6-9738E9DB361DQ39961306-C0583EC2-2AF3-410B-BE45-990A42B75C20Q41073067-7AC52044-B60A-4733-84D4-64E3E435C03BQ41108475-EC3BF5A8-1CB5-4796-BCF5-5ABA27DFBFA8Q41548189-C0C2C002-408C-49E0-9303-FB1F6B0190B5
P2860
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@ast
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@en
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@nl
type
label
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@ast
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@en
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@nl
prefLabel
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@ast
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@en
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@nl
P2093
P2860
P356
P1476
Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.
@en
P2093
Gijbels MJ
Havekes LM
HogenEsch H
van Vlijmen BJ
van den Maagdenberg AM
van der Boom H
P2860
P304
P356
10.1172/JCI117117
P407
P577
1994-04-01T00:00:00Z